Search Orphan Drug Designations and Approvals
-
| Generic Name: | chimeric monoclonal antibodies, c-alphaStx2 |
|---|---|
| Date Designated: | 10/04/2005 |
| Orphan Designation: | For treatment of shiga-toxin producing bacterial infection |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Taro Pharmaceuticals Inc. 130 East Drive Brampton Canada The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







